Efficacy and safety of dapagliflozin in children with kidney disease: real-world data
Dapagliflozin has not been associated with serious side effects. Further prospective clinical trials are needed to confirm the efficacy and safety of dapagliflozin in children with kidney disease.
Authors
- Hee Gyung Kang (ORCID: https://orcid.org/0000-0001-8323-5320)
- Naye Choi (ORCID: https://orcid.org/0000-0003-2966-9608)
- Jeesu Min (ORCID: https://orcid.org/0000-0003-1535-7769)
- Peong Gang Park (ORCID: https://orcid.org/0000-0002-4389-7917)
- Yo Han Ahn (ORCID: https://orcid.org/0000-0002-8185-4408)
- Hyeonju Lee (ORCID: https://orcid.org/0000-0003-0457-635X)
- Ji Hyun Kim (ORCID: https://orcid.org/0000-0001-8477-0157)
- Hye Won Park (ORCID: https://orcid.org/0000-0003-3543-6771)
Institutions
- Seoul National University (KR)
- Chungnam National University (KR)
- Korea University Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- Ajou University Hospital (KR)
- Seoul National University Children's Hospital (KR)
- National University College (PR)
- Ajou University (KR)
Publication Details
- Journal
- Pediatric Nephrology
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1007/s00467-024-06481-8
- Citations
- 9
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Seoul National University
- Seoul National University Hospital